$6.13 Billion is the total value of Eventide Asset Management's 152 reported holdings in Q4 2023. The portfolio turnover from Q3 2023 to Q4 2023 was 29.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
XMTR | Buy | XOMETRY INC | $204,340,289 | +176.1% | 5,690,345 | +30.5% | 3.34% | +150.8% |
TT | Buy | TRANE TECHNOLOGIES PLC | $195,061,708 | +21.6% | 799,761 | +1.2% | 3.18% | +10.4% |
ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $175,133,621 | +11.7% | 11,559,975 | +47.9% | 2.86% | +1.5% |
ODFL | Sell | OLD DOMINION FREIGHT LINE IN | $170,811,331 | -6.0% | 421,413 | -5.1% | 2.79% | -14.6% |
CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $143,966,316 | +227.0% | 3,630,013 | +126.9% | 2.35% | +197.1% |
ROP | Sell | ROPER TECHNOLOGIES INC | $128,939,792 | +12.3% | 236,513 | -0.3% | 2.10% | +2.0% |
CRWD | Buy | CROWDSTRIKE HLDGS INCcl a | $127,513,191 | +52.5% | 499,425 | +0.0% | 2.08% | +38.5% |
IDXX | Sell | IDEXX LABS INC | $124,316,214 | +26.9% | 223,973 | -0.0% | 2.03% | +15.2% |
PANW | Sell | PALO ALTO NETWORKS INC | $123,408,165 | -1.2% | 418,503 | -21.5% | 2.01% | -10.3% |
WCN | Buy | WASTE CONNECTIONS INC | $120,911,984 | +11.9% | 810,022 | +0.7% | 1.97% | +1.6% |
DHI | Buy | D R HORTON INC | $118,657,777 | +47.0% | 780,746 | +3.9% | 1.94% | +33.5% |
POOL | Sell | POOL CORP | $114,069,336 | +11.6% | 286,096 | -0.3% | 1.86% | +1.4% |
GH | Buy | GUARDANT HEALTH INC | $105,174,349 | -1.1% | 3,888,146 | +8.3% | 1.72% | -10.2% |
GLBE | Buy | GLOBAL E ONLINE LTD | $97,656,127 | +0.3% | 2,464,197 | +0.5% | 1.59% | -9.0% |
FLYW | Buy | FLYWIRE CORPORATION | $97,305,562 | -25.1% | 4,203,264 | +3.2% | 1.59% | -31.9% |
DDOG | Buy | DATADOG INC | $96,803,099 | +45.4% | 797,521 | +9.1% | 1.58% | +32.0% |
SWAV | Buy | SHOCKWAVE MED INC | $96,465,283 | +36.2% | 506,220 | +42.3% | 1.58% | +23.7% |
DLO | Sell | DLOCAL LTD | $95,925,139 | -8.6% | 5,422,563 | -0.9% | 1.57% | -16.9% |
ARGX | Sell | ARGENX SEsponsored adr | $93,498,662 | -40.8% | 245,771 | -23.5% | 1.53% | -46.3% |
LAD | Buy | LITHIA MTRS INC | $88,206,539 | +20.7% | 267,877 | +8.2% | 1.44% | +9.6% |
MTD | Sell | METTLER TOLEDO INTERNATIONAL | $87,724,906 | -27.0% | 72,323 | -33.3% | 1.43% | -33.7% |
EVH | Buy | EVOLENT HEALTH INCcl a | $87,164,386 | +21.3% | 2,638,946 | +0.0% | 1.42% | +10.1% |
HUBS | Buy | HUBSPOT INC | $81,994,889 | +18.8% | 141,239 | +0.8% | 1.34% | +7.9% |
COLL | Sell | COLLEGIUM PHARMACEUTICAL INC | $80,966,113 | +37.7% | 2,630,478 | -0.0% | 1.32% | +25.1% |
LOW | Sell | LOWES COS INC | $80,802,564 | -12.9% | 363,076 | -18.7% | 1.32% | -20.9% |
EXAS | Sell | EXACT SCIENCES CORP | $80,143,496 | -37.1% | 1,083,313 | -42.0% | 1.31% | -42.9% |
MIRM | Sell | MIRUM PHARMACEUTICALS INC | $78,630,919 | -37.1% | 2,663,649 | -32.7% | 1.28% | -42.9% |
TMDX | Buy | TRANSMEDICS GROUP INC | $78,475,363 | +54.9% | 994,240 | +7.4% | 1.28% | +40.6% |
MNDY | Buy | MONDAY COM LTD | $76,602,065 | +136.3% | 407,870 | +100.3% | 1.25% | +114.4% |
COUR | Buy | COURSERA INC | $76,275,263 | +10.5% | 3,937,804 | +6.6% | 1.24% | +0.3% |
TTD | Buy | THE TRADE DESK INC | $74,182,772 | -6.3% | 1,030,889 | +1.8% | 1.21% | -14.8% |
TREX | Buy | TREX CO INC | $73,069,461 | +34.3% | 882,588 | +0.0% | 1.19% | +22.0% |
DV | Buy | DOUBLEVERIFY HLDGS INC | $70,637,424 | +31.6% | 1,920,539 | +0.0% | 1.15% | +19.5% |
APTV | Buy | APTIV PLC | $70,472,638 | -8.9% | 785,473 | +0.1% | 1.15% | -17.3% |
LRCX | Sell | LAM RESEARCH CORP | $67,007,110 | -7.8% | 85,549 | -26.2% | 1.09% | -16.2% |
Buy | TOAST INCcl a | $66,650,205 | +21.6% | 3,650,066 | +24.7% | 1.09% | +10.5% | |
ENTG | Buy | ENTEGRIS INC | $64,340,584 | +35.0% | 536,977 | +5.8% | 1.05% | +22.5% |
MPWR | Buy | MONOLITHIC PWR SYS INC | $62,026,490 | +36.5% | 98,333 | +0.0% | 1.01% | +24.0% |
KRTX | Sell | KARUNA THERAPEUTICS INC | $60,136,900 | +4.7% | 190,000 | -44.1% | 0.98% | -4.9% |
FIVN | Buy | FIVE9 INC | $55,362,428 | +24.1% | 703,551 | +1.4% | 0.90% | +12.7% |
ASML | Sell | ASML HOLDING N V | $52,869,348 | +28.5% | 69,848 | -0.1% | 0.86% | +16.8% |
LNG | Buy | CHENIERE ENERGY INC | $51,421,778 | +2.9% | 301,223 | +0.0% | 0.84% | -6.6% |
Buy | AURA BIOSCIENCES INC | $51,411,763 | +89.5% | 5,802,682 | +91.8% | 0.84% | +71.9% | |
MARINUS PHARMACEUTICALS INC | $49,241,067 | +35.0% | 4,529,997 | 0.0% | 0.80% | +22.7% | ||
CYTK | CYTOKINETICS INC | $46,420,440 | +183.4% | 556,000 | 0.0% | 0.76% | +157.8% | |
NVT | Sell | NVENT ELECTRIC PLC | $45,445,942 | +8.8% | 769,097 | -2.4% | 0.74% | -1.1% |
KLAC | Buy | KLA CORP | $45,396,624 | +47.6% | 78,095 | +16.5% | 0.74% | +34.0% |
BILL | Buy | BILL HOLDINGS INC | $42,680,953 | +114.6% | 523,115 | +185.5% | 0.70% | +94.7% |
ARDX | Buy | ARDELYX INC | $42,194,063 | +283.7% | 6,805,494 | +152.5% | 0.69% | +248.0% |
TRGP | Sell | TARGA RES CORP | $41,494,498 | -15.8% | 477,662 | -16.9% | 0.68% | -23.5% |
CDW | Buy | CDW CORP | $41,035,806 | +20.6% | 180,520 | +7.0% | 0.67% | +9.5% |
DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $40,450,221 | +92.2% | 2,893,435 | +103.0% | 0.66% | +74.6% |
New | LEXEO THERAPEUTICS INC | $40,297,992 | – | 3,002,831 | +100.0% | 0.66% | – | |
LSCC | Buy | LATTICE SEMICONDUCTOR CORP | $38,312,148 | +4.2% | 555,329 | +29.7% | 0.62% | -5.4% |
PCVX | Buy | VAXCYTE INC | $38,132,537 | +90.3% | 607,206 | +54.5% | 0.62% | +72.8% |
CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $37,701,742 | +24.4% | 1,059,633 | +4.0% | 0.62% | +12.8% |
SPT | Sell | SPROUT SOCIAL INC | $36,049,244 | -26.9% | 586,739 | -40.7% | 0.59% | -33.7% |
NARI | INARI MED INC | $33,298,377 | -0.7% | 512,914 | 0.0% | 0.54% | -9.8% | |
FERG | Buy | FERGUSON PLC NEW | $32,891,791 | +37.0% | 170,362 | +16.7% | 0.54% | +24.3% |
ORLY | Buy | OREILLY AUTOMOTIVE INC | $29,554,139 | +5.8% | 31,107 | +1.2% | 0.48% | -4.0% |
SHW | Buy | SHERWIN WILLIAMS CO | $29,419,032 | +23.9% | 94,322 | +1.3% | 0.48% | +12.4% |
SNPS | Sell | SYNOPSYS INC | $29,005,910 | -20.0% | 56,332 | -28.7% | 0.47% | -27.5% |
BBIO | BRIDGEBIO PHARMA INC | $28,942,343 | +53.1% | 716,927 | 0.0% | 0.47% | +38.8% | |
BPMC | Sell | BLUEPRINT MEDICINES CORP | $28,813,378 | +30.8% | 312,374 | -28.8% | 0.47% | +18.7% |
AJG | Buy | GALLAGHER ARTHUR J & CO | $28,376,708 | +14.7% | 126,186 | +16.2% | 0.46% | +4.0% |
WMB | Buy | WILLIAMS COS INC | $27,739,065 | +4.7% | 796,413 | +1.3% | 0.45% | -4.8% |
AXSM | AXSOME THERAPEUTICS INC | $27,594,808 | +13.9% | 346,712 | 0.0% | 0.45% | +3.2% | |
VRNA | Buy | VERONA PHARMA PLCsponsored ads | $27,390,286 | +97.7% | 1,377,781 | +62.1% | 0.45% | +79.5% |
New | KORRO BIO INC | $26,185,357 | – | 546,325 | +100.0% | 0.43% | – | |
WDAY | Buy | WORKDAY INCcl a | $26,077,732 | +29.9% | 94,464 | +1.1% | 0.43% | +18.0% |
ISRG | Buy | INTUITIVE SURGICAL INC | $25,873,488 | +15.9% | 76,694 | +0.4% | 0.42% | +5.2% |
PNR | Buy | PENTAIR PLC | $25,749,592 | +20.4% | 354,141 | +7.2% | 0.42% | +9.4% |
IRTC | IRHYTHM TECHNOLOGIES INC | $25,597,010 | +13.6% | 239,135 | 0.0% | 0.42% | +3.2% | |
INSP | INSPIRE MED SYS INC | $25,447,059 | +2.5% | 125,090 | 0.0% | 0.42% | -7.0% | |
ACAD | New | ACADIA PHARMACEUTICALS INC | $25,342,032 | – | 809,391 | +100.0% | 0.41% | – |
EGP | Buy | EASTGROUP PPTYS INC | $25,334,026 | +128.9% | 138,030 | +107.7% | 0.41% | +108.0% |
PRVA | PRIVIA HEALTH GROUP INC | $23,030,000 | +0.1% | 1,000,000 | 0.0% | 0.38% | -9.0% | |
KROS | KEROS THERAPEUTICS INC | $23,060,800 | +24.7% | 580,000 | 0.0% | 0.38% | +13.3% | |
ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $22,778,939 | -57.7% | 180,857 | -68.6% | 0.37% | -61.6% |
IMGN | Sell | IMMUNOGEN INC | $22,622,950 | +9.7% | 763,000 | -41.3% | 0.37% | -0.5% |
STE | Sell | STERIS PLC | $21,737,229 | -2.4% | 98,873 | -2.6% | 0.36% | -11.2% |
MDB | Buy | MONGODB INCcl a | $21,666,597 | +759.2% | 52,994 | +626.8% | 0.35% | +686.7% |
ROL | Buy | ROLLINS INC | $21,412,711 | +17.0% | 490,330 | +0.0% | 0.35% | +6.4% |
RGEN | REPLIGEN CORP | $21,396,200 | +13.1% | 119,000 | 0.0% | 0.35% | +2.6% | |
ALV | Buy | AUTOLIV INC | $21,366,502 | +2520.8% | 193,906 | +2194.7% | 0.35% | +2226.7% |
NOVT | Sell | NOVANTA INC | $21,223,028 | +17.4% | 126,020 | -0.0% | 0.35% | +6.5% |
HLI | Buy | HOULIHAN LOKEY INCcl a | $21,016,506 | +31.1% | 175,269 | +17.1% | 0.34% | +19.1% |
CERE | CEREVEL THERAPEUTICS HLDNG I | $20,776,000 | +94.2% | 490,000 | 0.0% | 0.34% | +76.6% | |
INSM | INSMED INC | $19,684,383 | +22.7% | 635,185 | 0.0% | 0.32% | +11.5% | |
SRRK | New | SCHOLAR ROCK HLDG CORP | $18,287,380 | – | 972,733 | +100.0% | 0.30% | – |
ESI | Buy | ELEMENT SOLUTIONS INC | $18,103,001 | +35.0% | 782,325 | +14.4% | 0.30% | +22.4% |
RARE | ULTRAGENYX PHARMACEUTICAL IN | $17,167,380 | +34.1% | 359,000 | 0.0% | 0.28% | +21.7% | |
New | BIOHAVEN LTD | $17,167,123 | – | 401,101 | +100.0% | 0.28% | – | |
FANG | Sell | DIAMONDBACK ENERGY INC | $17,000,025 | -35.3% | 109,621 | -35.4% | 0.28% | -41.3% |
KRYS | New | KRYSTAL BIOTECH INC | $16,932,329 | – | 136,485 | +100.0% | 0.28% | – |
ALNY | New | ALNYLAM PHARMACEUTICALS INC | $16,652,670 | – | 87,000 | +100.0% | 0.27% | – |
MSCI | Sell | MSCI INC | $16,417,426 | +8.0% | 29,024 | -2.0% | 0.27% | -1.8% |
AMYLYX PHARMACEUTICALS INC | $16,439,841 | -19.6% | 1,116,837 | 0.0% | 0.27% | -27.2% | ||
CMS | Sell | CMS ENERGY CORP | $16,206,176 | -7.9% | 279,080 | -15.8% | 0.26% | -16.1% |
PRTA | PROTHENA CORP PLC | $16,176,933 | -24.7% | 445,155 | 0.0% | 0.26% | -31.6% | |
MASS | 908 DEVICES INC | $16,055,764 | +68.5% | 1,430,995 | 0.0% | 0.26% | +53.2% | |
VCYT | Sell | VERACYTE INC | $15,515,640 | -5.1% | 564,000 | -23.0% | 0.25% | -13.9% |
BRKR | BRUKER CORP | $15,457,620 | +17.9% | 210,365 | 0.0% | 0.25% | +6.8% | |
RPRX | Sell | ROYALTY PHARMA PLC | $14,999,358 | -45.0% | 533,975 | -46.8% | 0.24% | -50.0% |
RCKT | Sell | ROCKET PHARMACEUTICALS INC | $14,707,238 | -20.1% | 490,732 | -45.4% | 0.24% | -27.5% |
Buy | R1 RCM INC | $14,544,109 | +31.2% | 1,375,980 | +87.0% | 0.24% | +19.1% | |
VKTX | VIKING THERAPEUTICS INC | $13,957,500 | +68.1% | 750,000 | 0.0% | 0.23% | +53.0% | |
INZY | Buy | INOZYME PHARMA INC | $13,546,106 | +3.2% | 3,179,837 | +1.8% | 0.22% | -6.4% |
Sell | GXO LOGISTICS INCORPORATED | $13,465,597 | +4.3% | 220,170 | -0.0% | 0.22% | -5.2% | |
COGT | Buy | COGENT BIOSCIENCES INC | $13,129,852 | -37.4% | 2,232,968 | +3.9% | 0.21% | -43.2% |
Sell | ROIVANT SCIENCES LTD | $12,846,424 | -34.9% | 1,143,938 | -32.3% | 0.21% | -40.8% | |
APLS | New | APELLIS PHARMACEUTICALS INC | $12,558,269 | – | 209,794 | +100.0% | 0.20% | – |
IDYA | IDEAYA BIOSCIENCES INC | $11,919,300 | +31.9% | 335,000 | 0.0% | 0.20% | +20.4% | |
IEX | Sell | IDEX CORP | $11,863,542 | -2.2% | 54,643 | -6.3% | 0.19% | -11.0% |
SO | New | SOUTHERN CO | $11,850,631 | – | 169,005 | +100.0% | 0.19% | – |
NTLA | INTELLIA THERAPEUTICS INC | $11,362,556 | -3.6% | 372,665 | 0.0% | 0.18% | -12.7% | |
VST | Buy | VISTRA CORP | $11,282,778 | +200.6% | 292,907 | +158.9% | 0.18% | +174.6% |
VRSK | Buy | VERISK ANALYTICS INC | $11,120,127 | +24.3% | 46,555 | +22.9% | 0.18% | +13.0% |
RVMD | REVOLUTION MEDICINES INC | $10,353,480 | +3.6% | 361,000 | 0.0% | 0.17% | -6.1% | |
EHC | Sell | ENCOMPASS HEALTH CORP | $10,117,688 | -11.4% | 151,644 | -10.9% | 0.16% | -19.5% |
ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $9,586,643 | – | 313,289 | +100.0% | 0.16% | – |
ANAB | ANAPTYSBIO INC | $9,146,340 | +19.3% | 427,000 | 0.0% | 0.15% | +8.0% | |
SYY | Sell | SYSCO CORP | $8,793,809 | -1.3% | 120,249 | -10.9% | 0.14% | -10.0% |
GPI | Buy | GROUP 1 AUTOMOTIVE INC | $8,666,196 | +87.2% | 28,438 | +65.0% | 0.14% | +69.9% |
SRPT | Sell | SAREPTA THERAPEUTICS INC | $8,603,388 | -42.1% | 89,219 | -27.3% | 0.14% | -47.6% |
IRWD | New | IRONWOOD PHARMACEUTICALS INC | $8,471,938 | – | 740,554 | +100.0% | 0.14% | – |
SRE | New | SEMPRA | $8,395,168 | – | 112,340 | +100.0% | 0.14% | – |
INCY | New | INCYTE CORP | $7,629,487 | – | 121,508 | +100.0% | 0.12% | – |
EQIX | Sell | EQUINIX INC | $7,673,756 | -0.4% | 9,528 | -10.2% | 0.12% | -9.4% |
TGTX | New | TG THERAPEUTICS INC | $7,506,216 | – | 439,474 | +100.0% | 0.12% | – |
BEAM | BEAM THERAPEUTICS INC | $7,114,219 | +13.2% | 261,360 | 0.0% | 0.12% | +2.7% | |
PNFP | New | PINNACLE FINL PARTNERS INC | $7,050,952 | – | 80,841 | +100.0% | 0.12% | – |
CBT | New | CABOT CORP | $6,918,894 | – | 82,861 | +100.0% | 0.11% | – |
RCUS | ARCUS BIOSCIENCES INC | $4,584,000 | +6.4% | 240,000 | 0.0% | 0.08% | -2.6% | |
PCOR | New | PROCORE TECHNOLOGIES INC | $3,301,932 | – | 47,702 | +100.0% | 0.05% | – |
New | VYNE THERAPEUTICS INC | $3,248,803 | – | 1,394,336 | +100.0% | 0.05% | – | |
INTA | Buy | INTAPP INC | $3,271,089 | +13.5% | 86,036 | +0.1% | 0.05% | +1.9% |
ARTERIS INC | $2,350,245 | -9.5% | 399,023 | 0.0% | 0.04% | -19.1% | ||
XOMETRY INCnote 1.000% 2/0 | $1,983,447 | +29.6% | 2,100,000 | 0.0% | 0.03% | +14.3% | ||
Buy | LINDE PLC | $1,878,588 | +174.3% | 4,574 | +148.7% | 0.03% | +158.3% | |
SPGI | Buy | S&P GLOBAL INC | $1,853,708 | +123.0% | 4,208 | +85.0% | 0.03% | +100.0% |
TURNSTONE BIOLOGICS CORP | $1,802,667 | -35.4% | 708,317 | 0.0% | 0.03% | -42.0% | ||
NOW | Buy | SERVICENOW INC | $1,396,731 | +72.2% | 1,977 | +36.3% | 0.02% | +53.3% |
INTU | New | INTUIT | $1,233,809 | – | 1,974 | +100.0% | 0.02% | – |
SNV | New | SYNOVUS FINL CORP | $968,132 | – | 25,714 | +100.0% | 0.02% | – |
TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $912,600 | +53.3% | 8,775 | +28.1% | 0.02% | +36.4% |
NVDA | Buy | NVIDIA CORPORATION | $773,534 | +55.2% | 1,562 | +36.3% | 0.01% | +44.4% |
SHOP | Sell | SHOPIFY INCcl a | $697,283 | -4.4% | 8,951 | -33.1% | 0.01% | -15.4% |
ZTS | Buy | ZOETIS INCcl a | $622,308 | +60.0% | 3,153 | +41.0% | 0.01% | +42.9% |
EW | Sell | EDWARDS LIFESCIENCES CORP | $511,561 | -24.6% | 6,709 | -31.5% | 0.01% | -33.3% |
ALGN | Sell | ALIGN TECHNOLOGY INC | $307,154 | -47.7% | 1,121 | -41.8% | 0.01% | -54.5% |
AVTE | New | AEROVATE THERAPEUTICS INC | $275,588 | – | 12,178 | +100.0% | 0.00% | – |
COMP | Exit | COMPASS INCcl a | $0 | – | -111,613 | -100.0% | -0.01% | – |
WM | Exit | WASTE MGMT INC DEL | $0 | – | -3,173 | -100.0% | -0.01% | – |
PXD | Exit | PIONEER NAT RES CO | $0 | – | -6,938 | -100.0% | -0.03% | – |
PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -320,000 | -100.0% | -0.10% | – |
ELS | Exit | EQUITY LIFESTYLE PPTYS INC | $0 | – | -109,455 | -100.0% | -0.12% | – |
INBX | Exit | INHIBRX INC | $0 | – | -434,026 | -100.0% | -0.14% | – |
PLD | Exit | PROLOGIS INC. | $0 | – | -79,455 | -100.0% | -0.16% | – |
FREQ | Exit | FREQUENCY THERAPEUTICS INC | $0 | – | -3,597,122 | -100.0% | -0.18% | – |
EQT | Exit | EQT CORP | $0 | – | -316,200 | -100.0% | -0.23% | – |
DNLI | Exit | DENALI THERAPEUTICS INC | $0 | – | -621,850 | -100.0% | -0.23% | – |
BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -1,970,000 | -100.0% | -0.25% | – |
XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -413,906 | -100.0% | -0.25% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -164,299 | -100.0% | -0.26% | – |
NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -135,000 | -100.0% | -0.27% | – |
RPHM | Exit | RENEO PHARMACEUTICALS INC | $0 | – | -2,078,142 | -100.0% | -0.28% | – |
NEP | Exit | NEXTERA ENERGY PARTNERS LP | $0 | – | -588,359 | -100.0% | -0.31% | – |
BEPC | Exit | BROOKFIELD RENEWABLE CORPcl a sub vtg | $0 | – | -776,152 | -100.0% | -0.33% | – |
AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -513,876 | -100.0% | -0.47% | – |
MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -600,000 | -100.0% | -0.47% | – |
BEP | Exit | BROOKFIELD RENEWABLE PARTNERpartnership unit | $0 | – | -1,236,000 | -100.0% | -0.48% | – |
SGEN | Exit | SEAGEN INC | $0 | – | -130,990 | -100.0% | -0.50% | – |
HASI | Exit | HANNON ARMSTRONG SUST INFR C | $0 | – | -1,378,294 | -100.0% | -0.52% | – |
SHLS | Exit | SHOALS TECHNOLOGIES GROUP INcl a | $0 | – | -2,332,576 | -100.0% | -0.76% | – |
HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -689,732 | -100.0% | -1.43% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2024-02-20
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LOWES COS INC | 43 | Q2 2024 | 3.2% |
PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
VERACYTE INC | 41 | Q2 2024 | 1.5% |
NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-27 |
13F-HR | 2024-08-13 |
SC 13G/A | 2024-08-09 |
13F-HR | 2024-05-15 |
13F-HR/A | 2024-02-20 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.